You are here

antivirals

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Motley Fool

Fri, 11/19/21 - 10:52 am

Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haul

Fierce Pharma

Thu, 11/18/21 - 10:39 am

government contracts

Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill

Fierce Pharma

Tue, 11/16/21 - 10:45 pm

Pfizer to file for emergency authorization Tuesday for its Covid-19 pill

Stat

Tue, 11/16/21 - 10:43 pm

Pfizer agrees to let other companies make its COVID-19 pill

AP

Tue, 11/16/21 - 10:44 am

drug manufacturing

8 lingering questions about the new Covid pills from Merck and Pfizer

Stat

Mon, 11/15/21 - 10:38 am

Merck's COVID-19 antiviral pill vs. Pfizer's: What's the same, what's different

Beckers Hospital Review

Sat, 11/13/21 - 09:51 pm

US pays $1B to nearly double supply of Merck's COVID-19 pill

BioPharma Dive

Tue, 11/9/21 - 10:54 am

government contracts

Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%

CNBC

Fri, 11/5/21 - 12:54 pm

Merck’s Covid-19 antiviral pill receives first authorization in U.K.

Stat

Thu, 11/4/21 - 10:47 am

Merck sees up to $7B in coming sales of coronavirus pill

BioPharma Dive

Thu, 10/28/21 - 10:21 pm

Merck Inks Deal To Share Antiviral Covid Pill With Poorer Countries

Forbes

Wed, 10/27/21 - 10:59 am

EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data

Fierce Biotech

Mon, 10/25/21 - 10:58 am

Ridgeback Biotherapeutics

Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?

Motley Fool

Sun, 10/24/21 - 10:32 pm

Gilead Sciences

Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill

Stat

Wed, 10/20/21 - 10:07 am

Gates Foundation

Atea’s antiviral pill fails to clear Covid-19, forcing a re-think

Stat

Tue, 10/19/21 - 10:48 am

Atea Pharmaceuticals

clinical trials

Merck’s Covid-19 Pill Set for Review by FDA Advisory Panel

Bloomberg

Fri, 10/15/21 - 11:08 am

Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it

Fortune

Tue, 10/12/21 - 11:02 am

viral resistance

Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies

Forbes

Tue, 10/12/21 - 10:57 am

drug manufacturing

Merck asks FDA to authorize promising anti-COVID pill

NPR

Mon, 10/11/21 - 10:29 am

Ridgeback Therapeutics

Pages